Telekoms, Two

Deutsche Telekom's Two Frontiers: Fiber Reach, Sovereign Networks and a Clinical AI Bet

Published on 10/28/2026 at 06:01 | Editorial boerse-global.de
Telekom eyes T-Mobile US results due tomorrow and its own Q3 report on 5 November, as fiber build-out advances and T.Capital backs Tandem Health.
Telekoms, Two, Frontiers, Fiber, Reach, Sovereign, Networks, Clinical, Bet, Telekom Illustration mit AI erstellt.

Deutsche Telekom is expanding on several fronts at once, and the near-term scorecard investors will use to judge it is already taking shape. T-Mobile US quarterly figures are due tomorrow, with attention focused on the possible fallout from tougher competition in the American market, according to the Stuttgarter Zeitung. The group's own third-quarter 2026 report is then expected on 5 November.

On the network side, the Bonn-based carrier brought 255,000 new fiber connections into service in September, lifting the total number of households and businesses able to order tariffs of up to 2,000 Mbit/s to 14.4 million. The build-out figures, published yesterday, mark progress on availability — though reachable lines are not the same thing as booked contracts. In the third quarter of 2026 the fiber network grew to more than 900,000 kilometers, while roughly 500,000 households use hybrid connections that combine fixed-line and mobile access. The distinction between infrastructure that is available and infrastructure that is actually used remains central to any economic assessment of the rollout.

A managed-network push for business customers

Alongside the consumer build-out, Telekom is deepening its enterprise offering. Together with Rohde & Schwarz Networks and Cybersecurity, it announced yesterday a fully managed service for sovereign corporate networks, slated to launch before the end of 2026 and aimed at regulated industries as well as mid-sized and large companies. The LAN and WLAN technology is developed in Germany; Telekom handles operations and management, with cloud hosting in German data centers. Customers get an observer dashboard plus defined service and response times. The approach goes beyond simply providing a connection — Telekom takes on the running of corporate networks too, adding a concrete enterprise product to the build-out story.

Goldman flags the cost side

Marketing the infrastructure is one thing; spending discipline is another, and it remains a key valuation factor. Goldman Sachs responded positively to higher cost-savings targets, seeing room for upward estimate revisions if they are delivered. Bernstein Research had already taken a favorable view of operating developments, with analyst Ulrich Rathe calling the results after the quarterly figures at the time "boringly solid." Excluding T-Mobile US, revenue and EBITDA beat consensus estimates by 1% and 0.7% respectively.

Should investors sell immediately? Or is it worth buying Deutsche Telekom?

A Series B ticket to European healthcare AI

Separately, Telekom is placing a bet on artificial intelligence in healthcare through T.Capital, which is participating in the Series B financing round of Swedish company Tandem Health — an investment announced today. For shareholders this is first and foremost a long-term growth option, not evidence of near-term profit. Tandem develops an AI assistant for medical documentation, billing coding and clinical decision support, tying the commitment to concrete workflows in healthcare rather than a general AI thesis. According to Tandem, the assistant is used in more than 10,000 healthcare facilities across 14 European countries — a base for further growth, though it does not yet answer the investor question about future economic significance for Telekom.

The decisive test is whether Tandem can convert that existing usage into a sustainably scalable business. Beyond how many facilities deploy the software, it matters whether additional applications deepen customer relationships and generate economic value. By the company's own account, the software is integrated into around 130 patient record systems and carries Class IIa medical device certification under the EU Medical Device Regulation. Both point to an established foothold in medical workflows, but neither substitutes for an examination of the commercial outlook. A stake in a growing software vendor and a rising group profit are different things; operating reach becomes a reliable value driver only once it translates into economic progress.

Ambition versus delivery

In the favorable scenario, Tandem builds on its existing integration into healthcare facilities, developing further applications for patient navigation, appointment management and administration. Success there would extend the benefit beyond medical documentation into other workflows. The goal is ambitious: CEO Lukas Saari wants to give Europe's healthcare professionals back one billion working hours — a target, not a saving already achieved. T-Systems stresses in turn that any AI deployed must be trustworthy and secure, so a positive outcome would require Tandem to meet its users' reliability requirements as well as extend functionality. For Telekom, that would justify granting the stake long-term potential without deriving short-term earnings expectations from it.

The counterargument deserves equal weight: even growing usage at Tandem need not feed through to a noticeable advantage for Telekom shareholders any time soon. If development and adoption of further applications fall short of expectations, the stake stays a future option rather than a load-bearing valuation factor.

Deutsche Telekom at a turning point? This analysis reveals what investors need to know now.

Group-level numbers show why growth alone is not enough. In the second quarter of 2026, revenue rose to EUR 29.93 billion from EUR 28.67 billion a year earlier — yet higher sales do not automatically mean higher earnings per share. EPS in the same quarter came in at EUR 0.51, down from EUR 0.54 a year before. That comparison concerns the group as a whole and says nothing about Tandem's profitability, but it illustrates the yardstick against which new growth prospects must be measured.

As long as Tandem can turn its installed base into additional commercially viable applications, the investment remains a plausible long-term growth option. Should that conversion lag, the AI angle should carry less weight in valuations. For the near term, the group's own trajectory stays decisive — and the reports due tomorrow and on 5 November will show how solid that operating foundation really is.

Ad

Deutsche Telekom Stock: New Analysis - 28 October

Fresh Deutsche Telekom information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Deutsche Telekom analysis...

Disclaimer...
en | DE0005557508 | TELEKOMS | boerse | 70423948 |